Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Alzheon proposes IPO

Alzheon Inc. (Framingham, Mass.) proposed to raise up to $80.5 million on March 16 in

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE